Lyme Disease Vaccine: Pfizer & Valneva’s 70% Effective Shot Explained
Pfizer and Valneva have announced promising Phase 3 clinical trial data for PF-0730740, a novel Lyme disease vaccine demonstrating approximately 70% efficacy. This marks a significant step forward in preventing ... Read More